These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antihypertensive drug treatment changes in the general population: the CoLaus study. Christe V, Waeber G, Vollenweider P, Marques-Vidal P. BMC Pharmacol Toxicol; 2014 Mar 31; 15():20. PubMed ID: 24685255 [Abstract] [Full Text] [Related]
7. Costs of current antihypertensive therapy in Switzerland: an economic evaluation of 3,489 patients in primary care. Schäfer HH, Scheunert U. Swiss Med Wkly; 2013 Mar 31; 143():w13854. PubMed ID: 24163048 [Abstract] [Full Text] [Related]
10. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy. Dickson M, Plauschinat CA. Am J Cardiovasc Drugs; 2008 Mar 31; 8(1):45-50. PubMed ID: 18303937 [Abstract] [Full Text] [Related]
12. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension. Hilleman DE, Mohiuddin SM, Lucas BD, Stading JA, Stoysich AM, Ryschon K. Clin Ther; 1994 Mar 31; 16(1):88-102; discussion 87. PubMed ID: 7911403 [Abstract] [Full Text] [Related]
13. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. Burke TA, Sturkenboom MC, Lu SE, Wentworth CE, Lin Y, Rhoads GG. J Hypertens; 2006 Jun 31; 24(6):1193-200. PubMed ID: 16685222 [Abstract] [Full Text] [Related]
14. Long-term persistence with antihypertensive drugs in new patients. Degli Esposti E, Sturani A, Di Martino M, Falasca P, Novi MV, Baio G, Buda S, Volpe M. J Hum Hypertens; 2002 Jun 31; 16(6):439-44. PubMed ID: 12037702 [Abstract] [Full Text] [Related]
15. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. JAMA; 2002 Dec 18; 288(23):2981-97. PubMed ID: 12479763 [Abstract] [Full Text] [Related]
17. Antihypertensive persistence and drug class. Marentette MA, Gerth WC, Billings DK, Zarnke KB. Can J Cardiol; 2002 Jun 18; 18(6):649-56. PubMed ID: 12107422 [Abstract] [Full Text] [Related]
18. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. Corrao G, Zambon A, Parodi A, Poluzzi E, Baldi I, Merlino L, Cesana G, Mancia G. J Hypertens; 2008 Apr 18; 26(4):819-24. PubMed ID: 18327094 [Abstract] [Full Text] [Related]
19. Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker. Okano GJ, Rascati KL, Wilson JP, Remund DD, Grabenstein JD, Brixner DI. Clin Ther; 1997 Apr 18; 19(6):1433-45; discussion 1424-5. PubMed ID: 9444451 [Abstract] [Full Text] [Related]
20. Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data. Lachaine J, Petrella RJ, Merikle E, Ali F. Can J Cardiol; 2008 Apr 18; 24(4):269-73. PubMed ID: 18401466 [Abstract] [Full Text] [Related] Page: [Next] [New Search]